Evidence map›Paper›PMID 32612576›Full record

Trial reportFrontiers in endocrinology2020

Urinary Exosomal Thyroglobulin in Thyroid Cancer Patients With Post-ablative Therapy: A New Biomarker in Thyroid Cancer.

Tse-Ying Huang, Chih-Yuan Wang, Kuen-Yuan Chen, Li-Ting Huang

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Exosomes in esophageal cancer: function and therapeutic prospects.Medical oncology (Northwood, London, England) · 2024
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Observational
  20. CTC, ctDNA, and Exosome in Thyroid Cancers: A Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tse-Ying HuangDepartment of Internal Medicine, National Taiwan University Hospital Yun-Lin/Hsin-Chu Branch, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chih-Yuan WangDepartment of Internal Medicine, National Taiwan University Hospital Yun-Lin/Hsin-Chu Branch, College of Medicine, National Taiwan University, Taipei, Taiwan.
Kuen-Yuan ChenDepartment of Surgery, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Li-Ting HuangDepartment of Internal Medicine, National Taiwan University Hospital Yun-Lin/Hsin-Chu Branch, College of Medicine, National Taiwan University, Taipei, Taiwan.
National Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBiomarkersExosomesFemaleHumansIodine RadioisotopesMaleMiddle AgedProspective StudiesThyroglobulinThyroidectomyThyroid NeoplasmsBiomarkersIodine RadioisotopesThyroglobulinexosomegalectin-3thyroglobulinthyroid cancerurine

Identifiers

PMID32612576
PMCPMC7308545
OpenAlexW3035349181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.